Masao Matsuoka - Cell Biology

Author Information

Masao Matsuoka is a prominent researcher affiliated with the Department of Hematology, Rheumatology, and Infectious Diseases at the Kumamoto University Faculty of Life Sciences in Kumamoto, Japan. His work is primarily focused on the fields of hematology and infectious diseases, with a particular interest in viral oncology and cell biology.

Research Contributions

Masao Matsuoka has made significant contributions to the understanding of viral mechanisms and their role in oncogenesis. His research has explored various aspects of viruses such as HTLV-1 and HIV-1, examining their molecular interactions and potential therapeutic targets. Noteworthy areas of his research include the study of HTLV-1's impact on the NF-κB/YAP signaling pathway, the development of small molecules targeting HIV-1 capsid, and the persistence of retroviral antisense mRNAs in infected cells. His work has also delved into the pathophysiology of adult T-cell leukemia/lymphoma and multiple myeloma, providing insights into potential treatment strategies.

Aliases

Masao Matsuoka is also known by the aliases M Matsuoka and M. Matsuoka. These variations are often used in academic publications and citations.

Publication and Citation Metrics

Metric	Value
Total Papers Published	483
Total Citation Count	15,879
H-index	68

Publications:

Blocking cholesterol efflux mechanism is a potential target for anti-lymphoma therapy.

DOI: 10.1111/cas.15349

Year: 2022

HTLV-1 activates YAP via NF-κB/p65 to promote oncogenesis

DOI: 10.1073/pnas.2115316119

Year: 2022

[Adult T-cell leukemia/lymphoma diagnosed by RNA in situ hybridization for HTLV-1 bZIP factor].

DOI: 10.11406/rinketsu.63.89

Year: 2022

A Small Molecule, ACAi-028, with Anti-HIV-1 Activity Targets a Novel Hydrophobic Pocket on HIV-1 Capsid

DOI: 10.1128/AAC.01039-21

Year: 2021

Lysine Demethylase 5A Is Required for MYC-Driven Transcription in Multiple Myeloma.

DOI: 10.1158/2643-3230.BCD-20-0108

Year: 2021

Human retroviral antisense mRNAs are retained in the nuclei of infected cells for viral persistence

DOI: 10.1073/pnas.2014783118

Year: 2021

Feasibility of an intensified myeloablative conditioning regimen consisting of busulfan, fludarabine, cytarabine, and total body irradiation before single cord blood transplantation in elderly patients

DOI: 10.1007/s12185-021-03131-9

Year: 2021

HTLV-1's Foxy Strategy for Survival and Transmission

DOI: 10.3389/fviro.2021.792659

Year: 2021

Title HTLV-1 bZIP factor protein targets the Rb/E2F-1 pathway to promote proliferation and apoptosis of primary CD4+ T cells

DOI:

Year: 2021

The Role of CD38 in Multiple Myeloma Cell Biology

DOI: 10.1182/blood-2021-150884

Year: 2021

How is the Treatment Planned?

How Do Agonistic Antibodies Function?

What is Meiosis II?

What Are the Advantages of Flow Cytometry?

What are the Key Components?

How does Chemotherapy Work?

How do cells adapt to chronic inflammation?

Why is Super Resolution Microscopy Important in Cell Biology?

What is the Significance of Prokaryotic Cells in Biotechnology?

How is the cell cycle regulated?

Partnered Content Networks

Relevant Topics